BR112015002984A2 - composição, vacina para proteger um animal contra uma infecção com bactérias leptospira, e, uso de ácido cítrico. - Google Patents

composição, vacina para proteger um animal contra uma infecção com bactérias leptospira, e, uso de ácido cítrico.

Info

Publication number
BR112015002984A2
BR112015002984A2 BR112015002984A BR112015002984A BR112015002984A2 BR 112015002984 A2 BR112015002984 A2 BR 112015002984A2 BR 112015002984 A BR112015002984 A BR 112015002984A BR 112015002984 A BR112015002984 A BR 112015002984A BR 112015002984 A2 BR112015002984 A2 BR 112015002984A2
Authority
BR
Brazil
Prior art keywords
vaccine
protect
composition
citric acid
against infection
Prior art date
Application number
BR112015002984A
Other languages
English (en)
Inventor
Onno Rijke Eric
Leo Bernardus Maria Klaasen Henricus
Loeffen Peter
Original Assignee
Intervet Int Bv
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Intervet Int Bv filed Critical Intervet Int Bv
Publication of BR112015002984A2 publication Critical patent/BR112015002984A2/pt

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00Medicinal preparations containing antigens or antibodies
    • A61K39/02Bacterial antigens
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/12Carboxylic acids; Salts or anhydrides thereof
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/185Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19Carboxylic acids, e.g. valproic acid
    • A61K31/194Carboxylic acids, e.g. valproic acid having two or more carboxyl groups, e.g. succinic, maleic or phthalic acid
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00Medicinal preparations containing antigens or antibodies
    • A61K39/02Bacterial antigens
    • A61K39/0225Spirochetes, e.g. Treponema, Leptospira, Borrelia
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04Antibacterial agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00Medicinal preparations containing antigens or antibodies
    • A61K2039/51Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/52Bacterial cells; Fungal cells; Protozoal cells
    • A61K2039/521Bacterial cells; Fungal cells; Protozoal cells inactivated (killed)
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00Medicinal preparations containing antigens or antibodies
    • A61K2039/54Medicinal preparations containing antigens or antibodies characterised by the route of administration
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00Medicinal preparations containing antigens or antibodies
    • A61K2039/55Medicinal preparations containing antigens or antibodies characterised by the host/recipient, e.g. newborn with maternal antibodies
    • A61K2039/552Veterinary vaccine

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Immunology (AREA)
  • Microbiology (AREA)
  • Mycology (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Engineering & Computer Science (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Medicinal Preparation (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
BR112015002984A 2012-08-17 2013-08-16 composição, vacina para proteger um animal contra uma infecção com bactérias leptospira, e, uso de ácido cítrico. BR112015002984A2 (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP12180792 2012-08-17
PCT/EP2013/067132 WO2014027083A1 (en) 2012-08-17 2013-08-16 An immunogenic composition of killed leptospira bacteria

Publications (1)

Publication Number Publication Date
BR112015002984A2 true BR112015002984A2 (pt) 2018-06-12

Family

ID=48986146

Family Applications (1)

Application Number Title Priority Date Filing Date
BR112015002984A BR112015002984A2 (pt) 2012-08-17 2013-08-16 composição, vacina para proteger um animal contra uma infecção com bactérias leptospira, e, uso de ácido cítrico.

Country Status (11)

Country Link
US (1) US9375480B2 (pt)
EP (1) EP2884996B1 (pt)
JP (1) JP6502849B2 (pt)
CN (1) CN104582719B (pt)
AU (1) AU2013304048B2 (pt)
BR (1) BR112015002984A2 (pt)
DK (1) DK2884996T3 (pt)
ES (1) ES2772451T3 (pt)
PT (1) PT2884996T (pt)
RU (1) RU2667642C2 (pt)
WO (1) WO2014027083A1 (pt)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2023247622A1 (en) * 2022-06-22 2023-12-28 Intervet International B.V. Vaccine for protection against leptospira serovar icterohaemorrhagiae
WO2023247613A1 (en) * 2022-06-22 2023-12-28 Intervet International B.V. Vaccine for protection against leptospira serovar australis
WO2023247619A1 (en) * 2022-06-22 2023-12-28 Intervet International B.V. Vaccine for protection against leptospira serovar grippotyphosa

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3184384A (en) * 1961-09-07 1965-05-18 Dow Chemical Co Method of producing brucella abortus vaccine
DE69322268T2 (de) * 1992-04-30 1999-08-05 Cor Therapeutics Inc Stabile zusammensetzung von polypeptiden
US5925354A (en) * 1995-11-30 1999-07-20 Michigan State University Riboflavin mutants as vaccines against Actinobacillus pleuropneumoniae
US20050089533A1 (en) * 2003-01-29 2005-04-28 Joseph Frantz Canine vaccines against Bordetella bronchiseptica
JPWO2005063291A1 (ja) * 2003-12-25 2007-07-19 麒麟麦酒株式会社 抗体を含有する安定な水性医薬製剤
PE20100366A1 (es) * 2008-10-24 2010-05-21 Panacea Biotec Ltd Novedosas composiciones de vacuna con tos ferina acelular asi como el metodo para su elaboracion
BRPI0923006A2 (pt) * 2008-12-17 2016-03-08 Novartis Ag vacinas meningococicas incluindo receptor de hemoglobina
US8546149B2 (en) * 2010-08-27 2013-10-01 Intervet Inc. Potency test for vaccine formulations
CA2809758C (en) * 2010-09-10 2021-07-13 Wyeth Llc Non-lipidated variants of neisseria meningitidis orf2086 antigens

Also Published As

Publication number Publication date
DK2884996T3 (da) 2020-03-09
CN104582719B (zh) 2017-09-15
ES2772451T3 (es) 2020-07-07
US9375480B2 (en) 2016-06-28
AU2013304048B2 (en) 2018-03-01
US20150216976A1 (en) 2015-08-06
RU2667642C2 (ru) 2018-09-21
JP2015530372A (ja) 2015-10-15
EP2884996A1 (en) 2015-06-24
CN104582719A (zh) 2015-04-29
RU2015109124A (ru) 2016-10-10
PT2884996T (pt) 2020-02-21
JP6502849B2 (ja) 2019-04-17
EP2884996B1 (en) 2020-01-08
AU2013304048A1 (en) 2015-02-05
WO2014027083A1 (en) 2014-02-20

Similar Documents

Publication Publication Date Title
DK3061454T3 (da) Parasitiske orale veterinærsammensætninger omfattende systemisk-virkende aktivstoffer, fremgangsmåder og anvendelser deraf
BR112015003376A8 (pt) composto ou sal farmaceuticamente aceitável do mesmo, composição farmacêutica e usos de quantidade eficiente de composto ou sal farmaceuticamente aceitável do mesmo ou composição farmacêutica
EA201591004A1 (ru) Производные бороновой кислоты и их терапевтическое применение
DK2912074T4 (da) Dermal injicerbar steril sammensætning
EA201691988A1 (ru) Производные бороновой кислоты и их терапевтическое применение
CL2014000470A1 (es) Compuestos derivados del acido 2-oxo-piridin-3-carboxilico; composicion farmaceutica; combinacion; y su uso para tratar o mejorar una infeccion bacteriana.
BR112012022878A2 (pt) composto, composição farmacêutica, uso do compostos e método de tratamento
MX2016008448A (es) Conjugados de var2csa-farmaco.
EA201992133A1 (ru) Производные пиперидино-пиримидина для лечения вирусных инфекций
HK1198921A1 (en) Antimicrobial compositions comprising dgla, 15-ohepa and/or 15-hetre and methods of use thereof dgla15-ohepa / 15-hetre
HK1202415A1 (en) Pharmaceutical compositions comprising dgla, 15-ohepa, and/or 15- hetre and methods of use thereof dgla15-ohepa/ 15-hetre
BR112012022879A2 (pt) composto, composição farmacêutica, uso do composto e método de tratamento
BR112014014078A8 (pt) composições compreendendo constructos genéticos il-12 aperfeiçoados e vacinas, imunoterapêuticos e métodos de uso dos mesmos
DK3281607T3 (da) Implanterbar protese med acellulære vævsvedhæftninger.
BR112014010290A2 (pt) composição farmacêutica, métodos, composições e usos
BR112013022556A8 (pt) composição farmacêutica aquosa semissólida contendo tapentadol, seu uso e uso de tapentadol
CL2014003113A1 (es) Composición que comprende bacterias inactivadas de alliivibrio wodanis; método de producción; uso para fabricar medicamento para tratar y/o prevenir wodanosis; y vacuna para peces.
BR112013023575A8 (pt) novo derivado de octaidrotienoquinolina, composição farmacêutica compreendendo derivado, e uso destes
BR112015002984A2 (pt) composição, vacina para proteger um animal contra uma infecção com bactérias leptospira, e, uso de ácido cítrico.
BR112015003074A2 (pt) composição, vacina para proteger um animal contra uma infecção com bactérias leptospira, e, uso de ácido etilenodiaminatetra-acético.
CN105682672A8 (zh) 含有来自毛泡桐的香叶基黄酮作为有效成分的用于抑制神经氨酸酶活性的组合物
BR112015006272A2 (pt) ''uso cosmético, composto, composição cosmética e método de tratamento cosmético''
BR112015002727A2 (pt) combinação, uso de uma combinação, composição farmacêutica, uso de uma composição farmacêutica, kit, e, método para tratamento de uma infecção ou doença relacionada a tal infecção em humanos ou animais.
BR112015002726A2 (pt) combinação, uso de uma combinação, composição farmacêutica, uso de uma composição farmacêutica, kit, e método de tratamento de uma infecção ou doença relacionada a tal infecção em humanos ou animais.
BR112013033522A2 (pt) composição aquosa, composição injetável, polímero de ácido acrílico, e, uso de um polímero de ácido acrílico

Legal Events

Date Code Title Description
B06F Objections, documents and/or translations needed after an examination request according [chapter 6.6 patent gazette]
B06U Preliminary requirement: requests with searches performed by other patent offices: procedure suspended [chapter 6.21 patent gazette]
B09A Decision: intention to grant [chapter 9.1 patent gazette]
B11D Dismissal acc. art. 38, par 2 of ipl - failure to pay fee after grant in time
B350 Update of information on the portal [chapter 15.35 patent gazette]